×
About 8,062 results

ALLMedicine™ Vitiligo Center

Research & Reviews  3,861 results

Presence and the roles of IL-9/Th9 axis in Vitiligo.
https://doi.org/10.1111/pcmr.12978
Pigment Cell & Melanoma Research; Kumar S, Marathe S et. al.

Apr 9th, 2021 - Immune-dysregulation is critical in vitiligo pathogenesis. Although the presence and roles of numerous CD4+ T-cell subsets have been described, the presence of Th9 cells and more importantly, roles of IL-9 on melanocyte functions are not explored ...

Development of a shared decision-making tool in vitiligo: an international study.
https://doi.org/10.1111/bjd.20137
The British Journal of Dermatology; Shourick J, Ahmed M et. al.

Apr 8th, 2021 - Shared Decision-Making tools (SDMt) are visual tools developed to promote joint medical decision-making between physician and patient. In dermatology, there is a paucity of such tools. To develop and validate a SDMt in non-segmental vitiligo to be...

Correlation between gastrointestinal symptoms and adherence to traditional Persian medi...
https://doi.org/10.1515/jcim-2020-0192
Journal of Complementary & Integrative Medicine; Jaladat AM, Amiri-Ardekani E et. al.

Apr 5th, 2021 - Vitiligo is a chronic disease associated with the depigmentation of regions of the skin secondary to structural or functional damage to melanocytes. This damage results from interactions between the immune system and oxidative stress. In tradition...

Mogamulizumab-induced vitiligo in patients with Sézary syndrome: three cases.
https://doi.org/10.1684/ejd.2021.4002
European Journal of Dermatology : EJD; Algarni AS, Ram-Wolff C et. al.

Apr 5th, 2021 - Mogamulizumab is a novel defucosylated monoclonal antibody targeting the C-C chemokine receptor 4 (CCR4) that eradicates Sézary cells via antibody-dependent cellular cytotoxicity. Treatment of Sézary syndrome with mogamulizumab has recently shown ...

Basal cell carcinoma associated with non-neoplastic cutaneous conditions: a comprehensi...
https://www.ncbi.nlm.nih.gov/pubmed/33818975
Dermatology Online Journal; Cohen PR

Apr 5th, 2021 - Basal cell carcinoma (BCC) can be a component of a collision tumor in which the skin cancer is present at the same cutaneous site as either a benign tumor or a malignant neoplasm. However, BCC can also concurrently occur at the same skin location ...

see more →

Guidelines  3 results

Guidelines for the diagnosis and treatment of vitiligo in Japan.
https://doi.org/10.1111/1346-8138.12099
The Journal of Dermatology; Oiso N, Suzuki T et. al.

Feb 27th, 2013 - Vitiligo is an acquired pigment disorder in which depigmented macules result from the loss of melanocytes from the involved regions of skin and hair. The color dissimilarity on the cosmetically sensitive regions frequently induces quality of life ...

Guidelines for the management of vitiligo: the European Dermatology Forum consensus.
https://doi.org/10.1111/j.1365-2133.2012.11197.x
The British Journal of Dermatology; Taieb A, Alomar A et. al.

Aug 6th, 2012 - The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at national levels, but no common European viewpoint has emerged. T...

Guideline for the diagnosis and management of vitiligo.
https://doi.org/10.1111/j.1365-2133.2008.08881.x
The British Journal of Dermatology; Gawkrodger DJ, Ormerod AD et. al.

Nov 27th, 2008 - This detailed and user-friendly guideline for the diagnosis and management of vitiligo in children and adults aims to give high quality clinical advice, based on the best available evidence and expert consensus, taking into account patient choice ...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  3,947 results

Presence and the roles of IL-9/Th9 axis in Vitiligo.
https://doi.org/10.1111/pcmr.12978
Pigment Cell & Melanoma Research; Kumar S, Marathe S et. al.

Apr 9th, 2021 - Immune-dysregulation is critical in vitiligo pathogenesis. Although the presence and roles of numerous CD4+ T-cell subsets have been described, the presence of Th9 cells and more importantly, roles of IL-9 on melanocyte functions are not explored ...

Development of a shared decision-making tool in vitiligo: an international study.
https://doi.org/10.1111/bjd.20137
The British Journal of Dermatology; Shourick J, Ahmed M et. al.

Apr 8th, 2021 - Shared Decision-Making tools (SDMt) are visual tools developed to promote joint medical decision-making between physician and patient. In dermatology, there is a paucity of such tools. To develop and validate a SDMt in non-segmental vitiligo to be...

Correlation between gastrointestinal symptoms and adherence to traditional Persian medi...
https://doi.org/10.1515/jcim-2020-0192
Journal of Complementary & Integrative Medicine; Jaladat AM, Amiri-Ardekani E et. al.

Apr 5th, 2021 - Vitiligo is a chronic disease associated with the depigmentation of regions of the skin secondary to structural or functional damage to melanocytes. This damage results from interactions between the immune system and oxidative stress. In tradition...

Mogamulizumab-induced vitiligo in patients with Sézary syndrome: three cases.
https://doi.org/10.1684/ejd.2021.4002
European Journal of Dermatology : EJD; Algarni AS, Ram-Wolff C et. al.

Apr 5th, 2021 - Mogamulizumab is a novel defucosylated monoclonal antibody targeting the C-C chemokine receptor 4 (CCR4) that eradicates Sézary cells via antibody-dependent cellular cytotoxicity. Treatment of Sézary syndrome with mogamulizumab has recently shown ...

Basal cell carcinoma associated with non-neoplastic cutaneous conditions: a comprehensi...
https://www.ncbi.nlm.nih.gov/pubmed/33818975
Dermatology Online Journal; Cohen PR

Apr 5th, 2021 - Basal cell carcinoma (BCC) can be a component of a collision tumor in which the skin cancer is present at the same cutaneous site as either a benign tumor or a malignant neoplasm. However, BCC can also concurrently occur at the same skin location ...

see more →

News  229 results

Vitiligo Patients Share Their Experiences, Frustrations With Treatment Options With FDA
https://www.medscape.com/viewarticle/948528

Mar 31st, 2021 - Patients with vitiligo have faced significant impacts psychosocially and in many cases, profound losses of identity – and they've had only minimal success with treatment, according to participants who spoke at and provided input at a public meetin...

Topical Corticosteroid and Home-based Narrowband UVB for Localised Vitiligo
https://www.medscape.com/viewarticle/938697

Oct 8th, 2020 - Takeaway Combination treatment with hand-held narrowband-ultraviolet B (NB-UVB) light and potent topical corticosteroid (TCS) is likely to result in improved treatment response in patients with localised non-segmental vitiligo compared with potent...

Narrowband UVB for Vitiligo Linked to Lower Fracture Risk
https://www.medscape.com/viewarticle/937667

Sep 20th, 2020 - NEW YORK (Reuters Health) - Vitiligo patients who receive long-term narrowband UVB phototherapy are at lower risk of major osteoporotic fractures, new research shows. "Systemic phototherapy to treat vitiligo can unexpectedly reduce the risk of fra...

Dermatology therapies evolve as disease knowledge and investment grow
https://www.mdedge.com/dermatology/article/219314/medical-dermatology/dermatology-therapies-evolve-disease-knowledge-and/page/0/2?channel=27980

Mar 19th, 2020 - Spillover to other diseases JAK inhibitors – some in oral and some in topical form – are showing efficacy in ongoing research for alopecia areata (AA) and vitiligo as well, Dr. Blauvelt said.

Vitiligo tied to lower risk of internal malignancies
https://www.mdedge.com/dermatology/article/217491/pigmentation-disorders/vitiligo-tied-lower-risk-internal-malignancies?channel=39313
Bruce Jancin

Feb 19th, 2020 - LAHAINA, HAWAII – Individuals with vitiligo demonstrated a markedly reduced rate of internal malignancies in a recent first-of-its-kind “big data” study from South Korea, Iltefat Hamzavi, MD, said at the Hawaii Dermatology Seminar provided by Glob.

see more →

Patient Education  19 results see all →